The association between HER2 heterogeneity and various clinicopathological characteristics of breast cancer patients, including histological type, histological grade, age, T stage, N stage, and overall survival (OS), was analyzed and summarized in Table 3. Here, ERBB2 is linked to breast carcinoma.